NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
19/05/2026
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Tipo de processo
Eventos registrados
Atualização mais recente
Classificação
Tipo de marca
Classes Nice
Data de depósito
Data de registro
Data de expiração
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
Última transação
Escritório responsável
Código da situação
Cadastro oficial
Código do desenho
Tipo de titular
Localização do titular
Examinador
Unidade examinadora
Localização atual
Descrição da marca
The mark consists of a trefoil-like figure formed by a canted red equilateral triangle with a red droplet shape extending from each corner thereof, centered above the wording "MABQUEST THERAPEUTICS" in gray type.
Titulares
Representantes
Andrea L. Hintz Resonate IP, LLC
Classes Nice
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 1
Chemical, biochemical, biological and biotechnological preparations for use in industry and science other than for medical or veterinary use; chemical, biological and biotechnological preparations, in particular polypeptides and proteins for development or manufacture of reagents for use in industry and science; biological preparations, in particular polypeptides or proteins for use in laboratories and for non-medical diagnosis and analysis in industry and science; chemical and biochemical substances being additives for use in the manufacture of pharmaceuticals; chemical and biochemical substances for use in the manufacture of pharmaceuticals for treating cancer, autoimmune diseases, inflammatory disorders, and diseases in the fields of oncology and immunology; stem cells for research purposes; stem cells for scientific use; cultures of microorganisms other than for medical and veterinary use; cell culture media for scientific and research purposes
Classe 5
Pharmaceutical products for treatment of cancer, autoimmune diseases, inflammatory disorders, and diseases in the fields of oncology and immunology; medicinal preparations for disease treatment, namely, for preventing or treating cancer, autoimmune diseases, inflammatory disorders, and diseases in the fields of oncology and immunology; preparations for medical treatments, in particular preparations based on polypeptides and proteins for treatment of cancer, autoimmune diseases, inflammatory disorders, and diseases in the fields of oncology and immunology; protein complexes for diagnosing cancer, autoimmune diseases, inflammatory disorders, and diseases in the fields of oncology and immunology; synthetic peptides for pharmaceutical use, namely, for treatment of cancer, autoimmune diseases, inflammatory disorders, and diseases in the fields of oncology and immunology; diagnostic agents, preparations and substances for medical purposes; diagnostic substances for medical use; medicinal preparations and substances for preventing and treating cancer, autoimmune diseases, inflammatory disorders, and diseases in the fields of oncology and immunology; pharmaceutical preparations and substances for preventing and treating cancer, autoimmune diseases, inflammatory disorders, and diseases in the fields of oncology and immunology; agents and medicines for therapeutic use, namely, for the treatment of cancer, autoimmune diseases, inflammatory disorders, and diseases in the fields of oncology and immunology; cells for medical use; chemical, biochemical and biological preparations being biological, biochemical, and immunological pharmaceutical preparations for medical use
Classe 42
Analysis and research in laboratories being research laboratory analysis services in the field of chemistry, biochemistry, and molecular biology; scientific research and analysis in the field of chemistry, biochemistry, molecular biology, and immunology; cell culture for scientific research purposes, for others; design and development of medical technologies; research and development in the field of biotechnology; research and development in the field of microorganisms and cells; research and development in the field of diagnostic preparations; pharmaceutical research and development; biochemical research and development; scientific and technological research, particularly in the biochemical, diagnostic or pharmaceutical fields; research and development for the pharmaceutical industry; research and development services in the field of proteins, microorganisms and cells; research and development services in the field of immunology; services of a chemical, biochemical and biological research laboratory; research services, namely, analyses in the field of molecular biology
Histórico de despachos e eventos da marca no USPTO.
18 publicações encontradas
NOTICE OF REGISTRATION CONFIRMATION EMAILED
19/05/2026
REGISTERED-PRINCIPAL REGISTER
19/05/2026
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
31/03/2026
PUBLISHED FOR OPPOSITION
31/03/2026
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
25/03/2026
APPROVED FOR PUB - PRINCIPAL REGISTER
10/03/2026
TEAS/EMAIL CORRESPONDENCE ENTERED
09/03/2026
CORRESPONDENCE RECEIVED IN LAW OFFICE
09/03/2026
TEAS RESPONSE TO OFFICE ACTION RECEIVED
09/03/2026
REFUSAL PROCESSED BY IB
12/02/2026
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
24/01/2026
REFUSAL PROCESSED BY MPU
24/01/2026
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
15/12/2025
NON-FINAL ACTION WRITTEN
14/12/2025
ASSIGNED TO EXAMINER
12/12/2025
APPLICATION FILING RECEIPT MAILED
27/10/2025
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
27/10/2025
SN ASSIGNED FOR SECT 66A APPL FROM IB
23/10/2025
Proteção contínua da sua marca
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.